Matthias Kruse, MD, PhD

Matthias has over 20 years of medical & scientific expertise in early drug development, from translational science to Phase I – II.

He provides clinical pharmacology and therapeutic area consulting support to internal and external clients based on previous experience, background, and literature research, providing expert opinion/consulting services and scientific input and support to develop new methods and models.

Work experience

Prior to his role as Principal Consultant, Matthias was Head of Medical Writing, Pharmacokinetics and Pharmacometrics at Parexel. Matthias is a board-certified Clinical Pharmacologist, with diversified experience in the areas of basic and advanced pharmacokinetics, pharmacodynamics, toxicology and bio–pharmaceutical methodologies. He has broad expertise in study design, data analysis and interpretation of results including preparation of clinical study reports and market application documents.

Education

Matthias has specialization in Clinical Pharmacology, Free University of Berlin, Germany and holds a M.D and Ph.D. in Pharmacology & Toxicology with the University of Tübingen, Germany. He is also a member of the German Association for Applied Human Pharmacology and the Drug Information Association.